In the journals: B vitamins may protect against macular degeneration
In the journals
612After an average of 7.3 years, there were 55 cases of AMD among the women taking the supplement and 82 cases among those taking a placebo, a 34% difference. For visually significant (or worsening) AMD, there were 26 cases in the supplement group and 44 in the placebo group, a 41% difference. The advantage for the folic acid/B vitamin treatment began to emerge in the first two years of the study.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
